indeloxazine has been researched along with Neuroleptic Malignant Syndrome in 1 studies
indeloxazine: RN given refers to parent cpd without isomeric designation
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, H | 1 |
| Kikuchi, H | 1 |
| Ito, H | 1 |
| Yamamoto, A | 1 |
| Noda, S | 1 |
1 other study available for indeloxazine and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
[Case of malignant syndrome suggesting a central hyperthermic mechanism].
Topics: Antidepressive Agents; Female; Fever; Humans; Hypothalamus; Levodopa; Middle Aged; Morpholines; Neur | 1991 |